公司資料
Akero Therapeutics 股價、新聞與催化劑
- 股票代碼:
- AKRO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
目前無法取得 AKRO 的收盤價變動背景。
公司概覽
業務概覽
Akero Therapeutics is a metabolic-liver biotech focused on MASH and related liver-disease biology.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Akero sits in specialty biopharmaceuticals.
商業模式特徵
Its model depends on liver-disease data, dose optimization, and the potential to build a differentiated metabolic franchise.
生技產業定位
Akero is one of the more closely watched MASH names because efficacy signals can move the stock sharply.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。